Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets:: evidence for involvement of NK1 and 5-HT3 receptors
Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets:: evidence for involvement of NK1 and 5-HT3 receptors
复制标题
DOI：
10.1016/s0014-2999(01)01297-3
复制
发表时间：
2001-10-05
影响因子：
5
通讯作者：
Andrews, PLR
中科院分区：
文献类型：
--
作者：
Minami, M;Endo, T;Andrews, PLR
The effect of CP-99, 994, a tachykinin NK, receptor antagonist, on abdominal vagal afferent nerve activity in the ferret was investigated. Substance P (1 mug/kg, i.v.) increased vagal afferent activity by 449.0 +/- 51.9% and this was reduced to 145.9 +/- 5.7% (p < 0.01) by pre-treatment with CP-99, 994 (1 mg/kg, i.v.), and to 149.5 +/- 1.5% (p < 0.001) by granisetron 1 mg/kg, i.v.), a 5-HT3 receptor antagonist. In addition, the increase in vagal nerve activity induced by 5-HT (25 mug/kg, i.v., 552.0 +/- 57.0% increase from pre-injection level) was significantly reduced (401.3 +/- 10.6% increase from pre-injection level, p < 0.05) by CP-99, 994 (100 mug/kg i.v.). These results provide evidence for an involvement of peripheral NK1 and 5-HT3 receptors in substance P-induced vagal afferent activation. While the functional consequences (if any) of such peripheral effects were not investigated, they could contribute either directly (e.g. by blockade of receptors on vagal afferents) or indirectly (e.g. modulation of 5-HT release or reduction of local inflammatory response) to the antiemetic effects of CP-99, 994 against cisplatin and other emetic agents acting primarily via the vagus. (C) 2001 Elsevier Science B.V. All rights reserved.
